Beacon Rise Holdings Reports FY 2025 Loss and Unveils AIM Listing Strategy

Funding, share issuances and capital reorganisation

• 2025 share issues: 120,000 shares at £1.50 (24 April) and 111,149 at £1.60 (26 September), lifting share premium to £138,356.
• “Shares to be issued” reserve of £222,162 relates to 138,851 shares subscribed and then issued on 19 January 2026 at £1.60.
• March 2026: additional subscriptions raised approximately £250,000, with 138,889 ordinary shares to be issued.
• 12 March 2026: all £1 ordinary shares were sub-divided into £0.0001 ordinary shares and £0.9999 deferred shares; the company’s lifespan was extended by 12 months to 24 March 2027 at a general meeting.

Important caveat: despite forecasting sufficient funds through 30 April 2027 based on committed outflows and potential fund raises, the company states there are no binding agreements for future equity funding. That creates a material uncertainty over going concern until a firmer funding package is locked in.

Loss of capital and liquidity: why it matters

At year end, net liabilities were £7,458. That triggers Section 656 of the Companies Act (when net assets are half or less of called-up share capital), requiring the board to consider actions and convene a general meeting. The report says a meeting will be called in accordance with the requirements; separately, a general meeting took place on 12 March 2026 to extend the company’s life, approve a share capital reorganisation, adopt new articles and authorise the issue of new shares.

In short: cash was £72,529 at year end, and liquidity is tight. Continued operation depends on executing the AIM move, completing acquisitions, and raising further equity on acceptable terms.

Key risks and controls: the pre-revenue realities

• Liquidity risk: heightened. Controls include annual cash flow forecasts and board review, but fresh equity is still needed.
• IT risk: assessed as high, given target sectors. Daily backups, testing and disaster recovery planning are flagged.
• GDPR/data protection: current risk low, but expected to increase post-acquisition in healthcare operations.
• Price risk: exposure to rising professional advisory costs – visible in the 2025 cost base.
• Contingent fees: around £265,000 in success-based advisor fees for the proposed transactions, plus non-audit services from the auditor with expected total fees of £245,000 across 2025-26.

Ownership and board: control and credibility

Founder-CEO Xiaobing Wang holds 59.51% of the shares, with several other holders above 3%. Concentrated ownership can speed decision-making but also concentrates control. The addition of an experienced independent Chair, John Parker, and a public-markets CFO, Mark Tavener, should help with investor confidence and AIM readiness.

Josh’s take: promise with punchy execution risk

This is classic SPAC-to-operator territory. The strategy is clearer now – build a healthcare services group with an education spine – and the company has done the right pre-work on governance and team. Signing three Heads of Terms is encouraging, but until deals are executed and integrated, Beacon Rise remains pre-revenue and inherently high risk.

The positives: upgraded leadership, sharper sector focus, visible pipeline, and incremental funding coming in early 2026. The negatives: losses widened to £694,061, net liabilities at year end, and a formal going concern warning because future funding isn’t yet contracted. Expect dilution with the next raise; the pricing of new shares and the quality and profitability of acquired assets will drive value.

What to watch next in 2026

• AIM admission timing and the contents of the admission document.
• Definitive deal terms: purchase prices, funding mix, historic revenue and EBITDA of the three targets.
• Size and pricing of the next equity raise – and any cornerstone/strategic investors.
• Formation of Audit and Remuneration committees and further board strengthening.
• Integration plan and early KPIs (patient volumes, utilisation, margins) once acquisitions complete.
• Cash runway updates and confirmation of any non-dilutive financing options.

Where to find the source documents

The Annual Report will be available on the company’s website: beaconrise.uk. It will also be uploaded to the FCA’s National Storage Mechanism.

Bottom line: Beacon Rise is gearing up for a make-or-break year. If it lands the acquisitions and lists on AIM with a solid funding package, the story changes quickly. Until then, it’s one for investors comfortable with pre-revenue risk and potential dilution in pursuit of scale.